Results 71 to 80 of about 19,674,936 (195)

ANALISIS MOLEKULER GENOM VIRUS HEPATITIS C SERTA PERANANNYA DALAM PATOGENESIS INFEKSI

JKS (Jurnal Kedokteran Syiah Kuala), 2012
Abstrak. Virus Hepatitis C (HCV) adalah penyebab Hepatitis C, suatu penyakit yang masih menjadi masalah kesehatan di dunia, khususnya di Indonesia. Virus ini bergenom RNA untai tunggal yang berukuran sekitar 9,6 kilobasa.
Tristia Rinanda
doaj  

The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses

Viruses, 2020
Hepatitis C virus (HCV) infects ~71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma.
Eui-Cheol Shin, Ji Won Han, Wonseok Kang, Takanobu Kato, Seong-Jun Kim, Jin Zhong, Seungtaek Kim, Su-Hyung Park, Pil Soo Sung, Koichi Watashi, Jun Yong Park, Marc P. Windisch, Jong-Won Oh, Takaji Wakita, Kwang-Hyub Han, Sung Key Jang   +15 more
doaj   +1 more source

Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia between 1991 and 2007

Canadian Journal of Infectious Diseases and Medical Microbiology, 2011
BACKGROUND: In British Columbia (BC), hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccines are provincially funded for persons with chronic hepatitis infections.
Lily Fang, Amanda Yu, Jane A. Buxton
doaj   +1 more source

Perspectives of hepatitis C virus (HCV) elimination in Poland

Clinical and Experimental Hepatology, 2019
According to the World Health Organization (WHO) strategy, elimination of hepatitis C virus (HCV) as a major public health threat by 2030 includes diagnosis and cure of 90% of those infected between 2015 and 2030. The aim of this study is to estimate the realistic possibility to achieve the WHO elimination targets in Poland.The Polish population was ...
Robert Flisiak, Zarębska-Michaluk, Dorota   +1 more
openaire   +3 more sources

Ultrastructural Localization and Molecular Associations of HCV Capsid Protein in Jurkat T Cells

Frontiers in Microbiology, 2018
Hepatitis C virus core protein is a highly basic viral protein that multimerizes with itself to form the viral capsid. When expressed in CD4+ T lymphocytes, it can induce modifications in several essential cellular and biological networks.
Cecilia Fernández-Ponce, Maria C. Durán-Ruiz, Isaac Narbona-Sánchez, Juan P. Muñoz-Miranda, Mikel M. Arbulo-Echevarria, Antonio Serna-Sanz, Christian Baumann, Rocío Litrán, Enrique Aguado, Wilhelm Bloch, Francisco García-Cozar   +10 more
doaj   +1 more source

Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services. [PDF]

, 2011
In developed countries the majority of hepatitis C virus (HCV) infections occur in injecting drug users (IDUs) with prevalence in IDUs often high, but with wide geographical differences within countries.
Morongiu, A, V. D. HOPE, D. DE ANGELIS, Harris, R. J., Morongiu, A., DE Angelis, D, Hickman, Matthew, Ncube, F, R. J. HARRIS, Hope, V. D., Hope, VD, A. MORONGIU, de Angelis, D., Harris, RJ, Hickman, M, Ncube, F., M. HICKMAN, F. NCUBE   +17 more
core   +1 more source

Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001–2006)

Journal of Infection and Public Health, 2009
Summary: Background and aims: Prevalence of hepatitis C virus (HCV) in intravenous drug users (IDU) varies in different areas according to socioeconomic and geographical circumstances.
Seyed Mohammad Alavi, Leila Alavi
doaj   +1 more source

The management of patients positive to hepatitis C virus antibody in Malta [PDF]

, 2013
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease and hepatocellular carcinoma worldwide and is an important public health concern.
Deguara, Maria, Azzopardi, Neville, Mifsud Taliana, Kelly, Pocock, James, Rogers, Marilyn, Brincat, Anthea   +5 more
core  

Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus [PDF]

, 2008
Background The inhibitor telaprevir (VX-950) of the hepatitis C virus (HCV) protease NS3-4A has been tested in a recent phase 1b clinical trial in patients infected with HCV genotype 1. This trial revealed residue mutations that confer varying degrees of
Stefan Zeuzem, Albrecht, M., Hartmann, Christoph, Mayr, G., Andreas Schlicker, Welsch, C., Sarrazin, C., Susser, Simone, Sarrazin, Christoph, Lengauer, T., Albrecht, Mario, Christoph Welsch, Thomas Lengauer, Christoph Sarrazin, Antes, I., Mayr, Gabriele, Iris Antes, Simone Susser, Gabriele Mayr, Lengauer, Thomas, Susser, S., Zeuzem, S., Hartmann, C., Christoph Hartmann, Mario Albrecht, Schlicker, A., Francisco S Domingues, Domingues, Francisco S., Domingues, F., Welsch, Christoph, Schlicker, Andreas, Antes, Iris, Zeuzem, Stefan   +32 more
core   +1 more source

Update on chronic hepatitis C in hemophiliacs

Haematologica, 2002
BACKGROUND AND OBJECTIVES: Hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in patients affected by hereditary bleeding disorders and treated with non-virus inactivated clotting factor concentrates during the 1970s ...
M Franchini, F Capra, A Tagliaferri, G Rossetti, M De Gironcoli, P Rocca, G Aprili, G Gandini   +7 more
doaj